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Abstract
Previous studies have shown that the risk of multiple sclerosis (MS) is associated with season of birth with a higher proportion 
of MS patients being born in spring. However, this relationship has recently been questioned and may be due to confound-
ing factors. Our aim was to assess the influence from season or month of birth on the risk of developing MS in Sweden and 
Iceland. Information about month of birth, gender, and phenotype of MS for patients born 1940–1996 was retrieved from the 
Swedish MS registry (SMSR), and their place of birth was retrieved from the Swedish Total Population Registry (TPR). The 
corresponding information was retrieved from medical journals of Icelandic MS patients born 1981–1996. The control groups 
consisted of every person born in Sweden 1940–1996, their gender and county of birth (TPR), and in Iceland all persons born 
between 1981 and 1996 and their gender (Statistics Iceland). We calculated the expected number of MS patients born during 
each season and in every month and compared it with the observed number. Adjustments were made for gender, birth year, 
and county of birth. We included 12,020 Swedish and 108 Icelandic MS patients in the analyses. There was no significant 
difference between expected and observed MS births related to season or month of birth in Sweden or Iceland. This was even 
the results before adjustments were made for birth year and birth place. No significant differences were found in subgroup 
analyses including data of latitude of birth, gender, clinical phenotype, and MS onset of 30 years or less. Our results do not 
support the previously reported association between season or month of birth and MS risk. Analysis of birth place and birth 
year as possible confounding factors showed no major influence of them on the seasonal MS risk in Sweden and Iceland.
Keywords Multiple sclerosis · Month of birth · Risk factors · Epidemiology · Sweden · Iceland
Introduction
There is accumulating evidence that implies low sun expo-
sure and low levels of vitamin D as risk factors for multiple 
sclerosis (MS) [13, 15, 17]. This association may explain the 
increasing incidence and prevalence of MS observed with 
the distance from the equator [3, 20]. In fact, a gradient of 
increased MS prevalence with north latitude has also been 
reported in Sweden [1]. Moreover, low ultraviolet radiation 
of pregnant women during winter has been a reasonable 
explanation for the increased risk of MS observed in per-
sons born during spring and the reduced risk in those born 
during winter [26]. The changed risk of MS related to month 
of birth (MOB) has also been reported in the Scandinavian 
countries [10, 16, 21] including Sweden [22]. However, this 
relationship has recently been questioned, and confounding 
factors rather than biology were suggested to generate the 
association between MOB and MS risk [7, 8]. The highly 
variable birth rate, which is influenced by birth year and 
regional (birth county) variations, may be responsible for the 
previous findings [7, 8]. Although a recent study of Norway 
did take these confounding factors into account for, they 
claimed an increased MS risk in persons born in April [25]. 
In light of this, we conducted a study of association between 
season or MOB and the risk for developing MS in Sweden 
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and Iceland. Our aim was to compare our results with those 
previously published on MOB and MS risk from other popu-
lations and to clarify the effect from birth year and birth 
place as confounding factors.
Materials and methods
The study was based on two nationwide population cohorts 
of Sweden and Iceland. All patients had clinically definite or 
clinically probable MS according to Poser diagnostic criteria 
or MS according to the revised McDonalds criteria [18, 19].
Area and population
Sweden lies between latitudes 55° and 69° north in North-
ern Europe. There are 290 municipalities in Sweden. The 
population density is considerably higher in the southern 
part of the country. During the study period from 1940 to 
1996, the Swedish population increased from 6.4 to 8.8 mil-
lion people, the mean age increased from 37.0 years in 1968 
(the first year of registration of mean age) to 39.7 years, 
the birth rate per 1000 decreased from 15.1 to 10.8, and 
the mortality per 1000 decreased from 11.4 to 10.6. (http://
www.scb.se).
Iceland lies between latitudes 64° and 66°N. The popula-
tion of Iceland increased between 1981 and 1996 from 0.23 
to 0.27 million people, the mean age increased from 31.6 to 
33.9 years, the birth rate per 1000 decreased from 19.0 to 
16.2, and the mortality rate per 1000 decreased from 7.2 to 
7.0. In 1996, approximately 70% of the population lived in 
Reykjavik, the capitol of Iceland which lies at 64°N (http://
www.statice.is).
The Swedish registries
The Swedish MS registry (SMSR), started in 1996, became 
web based 2004, and 2008 included 14,500 of Sweden’s 
estimated 17,500 prevalence patients, giving coverage of 
80% [1, 11]. The registry serves as a national quality health 
care registry for Swedish MS patients. Patients with MS 
according to the Poser [19] or the McDonald criteria [18] 
have been prospectively or retrospectively registered (http://
www.neuroreg.se).
The Swedish Total Population Registry (TPR), founded in 
1947, registers residence over time for all residents in Swe-
den with some retrospectivity (http://www.scb.se). Before 
1961, there was a chance that individuals were not included 
in the registry if they lived unmarried together with another 
person and without children; however, thereafter, the regis-
try is complete [14].
The Swedish MS cohort
MS patients included in the study were born in Swe-
den between 1940 and 1996. This period was chosen to 
decrease the effect of decease bias for patients born before 
1940 and the possibility that patients born after 1996 might 
not yet have developed the disease. Deceased patients were 
included. At 31 January 2016, the day of data export, the 
following data were retrieved from the SMSR for every 
patient: personal identity number, month, season and year 
of birth, gender, date of MS onset, age at MS onset, age at 
data export, MS phenotype (relapsing–remitting (RRMS), 
secondary progressive (SPMS), progressive relapsing MS 
(PRMS), and primary progressive MS (PPMS), date when 
patients reach Expanded Disability Status Score (EDSS) 6 
[12]. The following data were retrieved from the TPR: place 
of birth.
The Swedish control cohort
We created a control group (n = 3,503,550) of every person 
born in Sweden 1940–1996, their gender and county of birth 
according to TPR.
The Icelandic MS cohort
The Icelandic MS patients were born in Iceland 1981–1996. 
There are no data available for persons born prior to 1981 in 
Iceland. Identical data as for the Swedish MS cohort were 
retrieved for Icelandic MS patients.
The patients were retrieved from different sources to 
make the cohort as complete as possible. The diagnosis 
searched for was: ICD10 (G35, G37.9), ICD9 (340, 341), 
and ICD8 (340, 341).
1. The neurology department at the Landspitali University 
Hospital; the only university hospital in Iceland which 
handles referrals for the whole country. Information was 
retrieved for both inpatients and outpatients.
2. All private practicing neurologists in Iceland.
3. Smaller hospitals and rehabilitation centers.
4. All patients approved for treatment of MS with disease 
modifying therapies, i.e., treatments in need of approval 
by a centralized agency.
5. Information from the Icelandic Social Security Agency 
to identify all who received disability benefits in Iceland.
The Icelandic control cohort
We created a control group (n = 65,114) from the Icelandic 
population born 1981–1996, divided according to gender 
(http://www.statice.is).
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Statistical methods
All tests were based on the observed numbers of births in 
a certain season or month. These observations were com-
pared to adjusted expected means. These adjusted means 
where derived from a simple Bernoulli distribution for 
each case with probabilities equal to the relative frequency 
of births in the MS case specific stratum (gender, birth 
year, and county). A central limit argument implies that we 
can use normal approximation for the null hypothesis ref-
erence distributions. By assuming independence between 
all Bernoulli distributions, we receive marginally larger 
variance than we would have got by taking multiple case 
correlations inside the strata into account.
Primarily, we look for over-representations, but we also 
acknowledge under-representations, if they would show 
up, using two-sided tests. The statistical approach was 
originally to test for seasonal effects [(March, April, May), 
(June, July, August), (September, October, November), 
and (December, January, February)]. When we did not find 
any signs of effects, there we started an exploratory phase 
of testing analyzing gender divided data, months instead 
of season, specific MS subgroups including early and late 
onset groups, and geographical north–south separation. 
Certainly, multiple correction problems arise in this sec-
ond step. However, the purpose of this step was partly to 
enable comparisons with findings in the Norwegian study 
[25] and confirm the negative findings in the first step. For 
more arguments behind this approach, cf. the discussion 
section below.
A normal test was used with the null hypothesis that 
there is no difference in the probability of getting MS 
for male or female depending on the birth date. This null 
hypothesis was tested against an alternative hypothesis 
that there is an increased risk getting the disease in a 
certain period. We used the Bernoulli estimation model 
to calculate the expected number of MS patients being 
born in every month and compared it with the observed 
number with a two-sided T test (p = 0.05). The calcula-
tions were done with and without adjustments for gender, 
year of birth, and county of birth as suggested by Fiddes 
et al. [7]. This test was also applied when the cohort was 
divided according to birth in Southern or Northern Swe-
den. We divided Sweden into two regions, a northern and 
a southern region, divided at the geographical middle of 
Sweden, i.e., 62″N. Thereafter, we calculated the observed 
vs expected MS MOB in the two regions. Similar tests 
were used for subgroup analysis related to gender, MS 
phenotype (RRMS, SPMS, PPMS), and early onset age 
(≤ 30 years of age). The statistical testing procedure is 
described in Supplement 1.
The calculation was done using Matlab (Mathworks, 
Natick, MA, USA).
The study was approved by the regional ethical review 
board of Gothenburg, Sweden and Icelandic National Bio-
ethics Committee and Data Protection Authority.
Results
The Swedish MS cohort
We included 12,020 MS patients born in Sweden 
1940–1996. The export from the MS registry was made 
31st of January 2016. At that date, the SMSR included 
15,801 patients, 14,157 of them were born in Sweden, 
13,398 of them were born 1940–1996, and 12,020 of 
them had information of place of birth. The mean age 
of this final cohort was 51 years (median 51 years). The 
mean age at MS onset (n = 11,137) was 32.9 years (range 
1–70 years). The mean age at MS diagnosis (n = 10,065) 
was 37.4 years (range 6–73 years). The female:male ratio 
was 2.5:1. MS phenotype was available for 11,412 patients: 
RRMS (n = 7087, 62.0%), PPMS (n = 932, 8.2%), PRMS 
(n = 154, 1.3%), and SPMS (n = 3239, 28.4%). There 
were 87.6% (n = 10,283) living in the Southern region of 
Sweden and 12.4% (n = 1458) in the Northern region of 
Sweden.
The risk of MS according to season and month 
of birth
We found no relationship between season of birth and the 
risk of developing MS later in life (Supplement 2). Neither 
did we find any difference between observed and expected 
number of MS patients when each MOB was analyzed sepa-
rately (Fig. 1) with or without adjustments for birth year and 
county of birth. With adjustments, there seemed to be 7% 
more MS births in February than expected (1030 vs 961.8 
p = 0.0208, Supplement 3). However, when Bonferroni cor-
rection is done, this difference is far from significant. To 
reject the null hypothesis for 5% level, we would need a p 
value of less than 0.0042 for statistical significance (0.0084 
in case of one sided tests).
The risk of MS associated with month of birth 
and latitude
When latitude was tested, there were 10% more MS births 
in February than expected in the Southern region of Sweden 
(900 vs 824.5, p = 0.00574). After Bonferroni correction for 
multiple comparisons, the effect was not statistically signifi-
cant (Supplements 4 and 5).
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The risk of MS associated with month of birth 
and gender
No significant difference was found in observed vs expected 
births when gender was taken into account. There was a 
trend towards more MS births in February both in men (303 
vs 276.9 p = 0.099) and females (727 vs 685.0 p = 0.0912).
The risk of MS associated with month of birth 
and phenotype
No effect of MOB was seen on the risk of MS when the 
cohort was divided according to MS phenotype.
The risk of MS associated with month of birth 
and early age of MS onset (≤ 30 years of age)
In spring, there were fewer MS births than expected (1372 
vs 1442.0 p = 0.0285), but a p value of 0.0125 or lower 
would have been needed to reach statistical significance after 
correction for multiple tests (Supplement 6). Nor did we 
find any significant differences in the number of MS births 
related to month.
The Icelandic MS cohort
At the 01st of January 2016, we included 108 patients born 
in Iceland from 1981 to 1996. The mean age of the cohort 
was 30.1 years (range 20–35 years), the mean age at MS 
onset was 22.5 years (range 10–37 years), and the mean age 
at MS diagnosis was 23.7 years (range 13–39 years). The 
female:male ratio was 2.1:1.
The risk of MS according to season and month 
of birth
We found no relationship between season of birth and the 
risk of developing MS later in life (Supplement 7). Neither 
did we find any difference between expected and observed 
number of Icelandic MS patients when each MOB was ana-
lyzed separately (Supplement 8). In our original analysis, 
there seemed to be fewer MS births in the autumn (17.0 vs 
26.9, p = 0.028). After correction for multiple tests, this 
effect disappeared.
Discussion
Our study showed no influence from season of birth or MOB 
on the risk of developing MS later in life in Sweden or Ice-
land with or without adjustments for possible confounding 
factors [7]. Even in the subgroup analysis, no observations 
remained as statistically significant after correction for mul-
tiple hypothesis testing, which confirms the negative result 
in the seasonal analysis. The only month that showed higher 
MS births was February, where we observed 7% more MS 
cases than expected. This corresponds to a p value of 2.08% 
before any multiple corrections. This significance disap-
peared after correction for multiple testing. Although low 
vitamin D levels during fetal development might be a risk 
factor for developing MS later in life [6], our results did not 
support that this risk is associated with season of birth or 
MOB.
In a recent study from Norway, including a cohort of 
6649 MS patients born 1930–1979 [25], they found a 10% 
increase in MS births in April, a 15% increase in Decem-
ber, and, in contrast with our study, a 13% decrease in 
February before any cofounding factors adjustments. How-
ever, after correction for birth year, the increase in Decem-
ber disappeared, and after correction for birth county, the 
decrease in February became non-significant. However, 
a 10% increase in birth of the Norwegian MS patients 
remained in April, and this increase was also significant 
when comparing the incidence of MS in siblings, moth-
ers, and fathers. Although the authors concluded that there 
was an increased risk in April births in the MS population, 
Fig. 1  Seasonality of MS births 
in Sweden, with adjustments 
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the significance disappeared after correction for multiple 
testing. We showed only marginally smaller observed MS 
cases in April.
We also found that the MS incidence was higher than 
expected in February in the Southern region of Sweden. 
The p value is 0.5% but not significant after correction for 
months. Moreover, this association was not in line with 
the previous hypothesis, suggesting an increased MS risk 
with northern latitude, less sun exposure and low D vitamin 
levels.
In contrast with our results, a previous study from 
Sweden showed more cases of MS than expected in June 
(11%) and fewer than expected in December and January 
(8 and 10%), respectively [22]. Although their MS patients 
(n = 9461) were also retrieved from the SMSR registry, their 
study population and controls differed from ours in several 
aspects. Their patients had a median birth year of 1957 and 
included all patients registered in the SMSR until 2008. Our 
study cohort was younger with a median birth year of 1965, 
and included only patients born between 1940 and 1996 to 
decrease the effect of decease bias for patients born before 
1940 and the possibility that patients born after 1996 might 
not yet have developed MS. However, even with our study 
design, we might have missed patients born after 1940 who 
due to severe MS died before 1996 when the SMSR was 
established. This limitation in year of birth influenced the 
size of the control cohort, and neither did we include con-
trols from municipalities that did not have a case of MS. 
Another factor that should be noted is the change of MOB 
of patients with MS over recent years. In contrast with the 
previous investigation [22], we found no increased MS risk 
related to birth in June in patients registered after 2008. 
Table 1  Owerview over studies of birth month and MS risk
a Not defined
b Incidence rate ratio for two-month period with May–June as the reference period (1.0)























Sweden [21] Salzer J et al. 2010 1900–2007 9361 12,116,853 11% more in 
June, 8 and 




Italy [23] Sotgiu et al. 2006 nda 810 247,612 More births in 
spring months
No/no





Australia [24] Staples et al. 2010 1920–1950 1524 2,468,779 1.34 risk for 






Kuwait [2] Akhtar et al. 2015 1950–2013 1035 3,454,222 13% more in 
December
No/yes
Portugal [4] Barros et al. 2013 1992–1943 421 1,150,362 No seasonal 
difference
No/yes
Norway [25] Torkildsen et al. 2014 1930–1979 6649 2,899,260 No seasonal 
difference
Yes/yes
Finland [21] Saastamoinen 
et al.







Fragoso et al. 2013 nda 1207 1207 No seasonal 
difference
Yes/yes
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Moreover, no correction for year of birth or county of birth 
was made when analyzing the MS risk in that study. They 
used 2 × 2 Chi-squared test for calculating MOB and MS 
risk. Applying that test to our data for a direct comparison 
did not influence our results.
We searched PubMed and Scopus for studies investigat-
ing the possible influence from season of birth or MOB on 
the risk of developing MS (Table 1). Except for the Norwe-
gian study [25], other studies have not adjusted the results 
for birth year and birth place. They have made adjustments 
for either birth place [2, 4, 5, 24], or birth year [21], or 
none of these confounding factors [26]. However, without 
adjustments, similar result as we found was found in a South 
African study [9] and in a study from Portugal with 1207 
MS patients and 1207 match controls, after adjusting the 
material for latitude of birth and gender [4]. However, birth 
year was not taken into account in this analysis. In all other 
studies, an association has been showed between increased 
MS risk and birth during spring and/or a decreased MS risk 
in persons born during autumn or winter [5, 21–24, 26] or 
the opposite in a study from the Southern hemisphere [2].
The main strength of our study is that data was retrieved 
from national registries with high patient recovery. The 
Swedish MS registry had high coverage, estimated about 
80% of all cases according to the National Patient Registry 
(NPR) at the National Board of Health and Welfare (http://
www.socialstyrelsen.se) [11]. In a previous study, we found 
that the rate of older MS patients might be lower in the 
SMSR than in the NPR, while early MS cases are almost 
completely included, but there might be regional variation 
in the inclusion rate [1]. However, these differences should 
not have influenced the result of our study. The Icelandic 
data were population based and probably included all MS 
patients in Iceland. Although we did not remove MS cases 
from the general Icelandic population, this should have mini-
mal effect on the results due to the small number.
In conclusion, our results did not support the previously 
reported association between season or MOB and MS risk. 
Our results were unaffected by adjustments for possible 
confounding factors, and therefore, it remains unclear if 
those are responsible for the previously reported relation-
ship between birth during spring and an increased MS risk 
[7]. Thus, our results do not support the hypothesis that 
pregnancy during autumn and winter with low levels of sun 
exposure and low vitamin D levels influence the risk of MS.
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